Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit.
A panel of experts discussed the transition of care between community and academic centers at the CURE Educated Patient ...
Triplet therapy with bortezomib, lenalidomide and dexamethasone — a regimen often referred to as VRd — is a current standard ...
A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first ...
Groundbreaking research at the Yale Cancer Center offered hope for patients diagnosed with Multiple Myeloma, a type of blood ...
While we've known that a healthy diet reduces the overall chance of getting cancer, there's now evidence that one eating plan ...
The FDA has accepted the resubmitted BLA for linvoseltamab for patients with relapsed/refractory multiple myeloma.
What Is Refractory Multiple Myeloma? Multiple myeloma is a cancer that affects a type of white blood cell called a plasma cell, which helps your immune system fight infections. Refractory means ...
The following is a summary of “Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma ...
Patients who did not complete a distress screener were also less likely to receive autologous stem cell transplants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback